- Home
- PPC vs ASND Comparison
PPC vs ASND Comparison
Compare PPC & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPC
- ASND
- Stock Information
- Founded
- PPC 1946
- ASND 2006
- Country
- PPC United States
- ASND Denmark
- Employees
- PPC N/A
- ASND 1017
- Industry
- PPC Meat/Poultry/Fish
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- PPC Consumer Staples
- ASND Health Care
- Exchange
- PPC Nasdaq
- ASND Nasdaq
- Market Cap
- PPC 10.4B
- ASND 12.1B
- IPO Year
- PPC 1987
- ASND 2015
- Fundamental
- Price
- PPC $41.39
- ASND $199.37
- Analyst Decision
- PPC Hold
- ASND Strong Buy
- Analyst Count
- PPC 4
- ASND 16
- Target Price
- PPC $47.50
- ASND $240.75
- AVG Volume (30 Days)
- PPC 1.4M
- ASND 370.3K
- Earning Date
- PPC 10-29-2025
- ASND 11-13-2025
- Dividend Yield
- PPC 20.27%
- ASND N/A
- EPS Growth
- PPC 62.69
- ASND N/A
- EPS
- PPC 5.19
- ASND N/A
- Revenue
- PPC $18,177,417,000.00
- ASND $576,332,355.00
- Revenue This Year
- PPC $3.90
- ASND $102.31
- Revenue Next Year
- PPC $0.67
- ASND $76.44
- P/E Ratio
- PPC $7.98
- ASND N/A
- Revenue Growth
- PPC 2.06
- ASND 54.50
- 52 Week Low
- PPC $40.92
- ASND $118.03
- 52 Week High
- PPC $57.16
- ASND $208.16
- Technical
- Relative Strength Index (RSI)
- PPC 28.64
- ASND 57.01
- Support Level
- PPC $41.95
- ASND $193.00
- Resistance Level
- PPC $43.22
- ASND $200.55
- Average True Range (ATR)
- PPC 1.08
- ASND 5.87
- MACD
- PPC -0.19
- ASND -0.85
- Stochastic Oscillator
- PPC 10.30
- ASND 48.20
About PPC Pilgrim's Pride Corporation
Pilgrim's Pride is the second-largest poultry producer in the US (59% of 2024 sales), the UK (29% including other European sales), and Mexico (12%). Its UK and European arm also includes pork operations from the 2019 acquisition of Tulip. Pilgrim's sells to chain restaurants, food processors, food distributors, and retail chains. Most of its US and Mexican sales come from fresh chicken, while prepared chicken and pork constitute most of its UK and European sales. JBS owns more than 80% of Pilgrim's Pride's outstanding shares, though it failed to acquire the remaining stake in 2021 after a special board committee deemed that JBS' offer undervalued Pilgrim's Pride.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.